Abstract: An image compensation circuit for controlling a luminance of a display panel is configured to: receive a plurality of image data; perform gamma tuning to convert the plurality of image data into a plurality of original gamma codes according to a plurality of first compensation values corresponding to a first operation mode; calculate a plurality of gamma difference values between the plurality of first compensation values and a plurality of second compensation values corresponding to a second operation mode; and calculate a plurality of output gamma codes corresponding to the second operation mode according to the plurality of original gamma codes by using the plurality of gamma difference values.

Abstract: The invention provides a color calibration device, a color calibration method and a calibration table generation method. The color calibration device includes a calibration table circuit, a ratio circuit and an image processing circuit. The calibration table circuit provides a selected calibration table including a plurality of zone calibration parameters. Each of the zone calibration parameters corresponds to a corresponding zone among a plurality of zones of a display panel. The ratio circuit calculates a subpixel calibration parameter corresponding to a current subpixel according to at least one of the zone calibration parameters in the selected calibration table. The image processing circuit calibrates original subpixel data of the current subpixel according to the subpixel calibration parameter to generate calibrated subpixel data of the current subpixel.

Abstract: A photosensitive resin composition and a display device including the same are provided.

Abstract: Provide are a detector module, a detector, and a medical device. The detector module includes a plurality of detection sub-modules at least partially arranged in a stepped manner in a first direction. Each of the plurality of detection sub-modules includes a plurality of photoelectric conversion units arranged at intervals in a second direction intersecting with the first direction. One of two adjacent detection sub-modules is located at a higher step as a first detection sub-module, and the other one is located at a lower step and as a second detection sub-module. A first gap is formed between the plurality of photoelectric conversion units of the first detection sub-module. A second gap is formed between the plurality of photoelectric conversion units of the second detection sub-module. A width of the first gap in the second direction is smaller than a width of the second gap in the second direction.

Abstract: The present invention relates to a novel compound, which has cancer therapeutic activity. The present invention also relates to a preparation method for the compound and a pharmaceutical composition containing the compound.

Abstract: An organic compound and an organic light emitting device including the same are disclosed. For example, an organic compound is represented by the following chemical formula in which one of X1 and X2 is N, and the other one of X1 and X2 is O or S. The organic light emitting diode and the organic light emitting device each includes the organic compound.

Abstract: A light emitting device and a light emitting display including the same. The light emitting device includes an anode and a cathode facing each other, a first stack and a second stack disposed between the anode and the cathode, the first stack including a first electron transport layer comprising a first material represented by Formula 1, a first blue light emitting layer containing a boron-based compound emitting light having a wavelength of 430 nm to 480 nm, and a first electron-blocking layer including a second material including a spirofluorene group, and at least one hydrogen atom on at least one side of the spirofluorene group is substituted by deuterium, and the second stack including at least two phosphorescent light emitting layers emitting light having a longer wavelength than that of the light emitted by the first blue light emitting layer, and a charge generation layer.

Abstract: An organic compound and an organic light emitting device including the same are disclosed. For example, an organic compound is represented by the following chemical formula in which one of X and Y is N, and the other one of X and Y is O or S. The organic light emitting diode and the organic light emitting device each includes the organic compound.

Abstract: A light emitting device and a light emitting display device that are capable of improving efficiency, driving voltage, and lifespan by varying the configuration of a layer adjacent to a blue light emitting layer in a blue fluorescent stack contacting a cathode are disclosed. The light emitting device includes stacks between an anode and a cathode, wherein an nth stack contacting the cathode is a first blue stack that includes a first hole transport layer, a first electron-blocking layer, a first blue light emitting layer containing a boron-based dopant having an emission peak of 430 nm to 480 nm, a first electron transport layer contacting the first blue light emitting layer, and an electron injection layer having two sides contacting the first electron transport layer and the cathode, respectively, wherein the first electron transport layer contains a mixture of a first material and a second material.

Abstract: An organic compound including a first moiety having a hetero-ring fused acridine moiety and a second moiety having a quinazoline ring linked to the first moiety directly or via a bivalent linking group is disclosed. In the organic compound, at least one hydrogen atom may be substituted with deuterium or a deuterium-substituted group. An organic light emitting diode (OLED) and an organic light emitting device including the organic compound are also disclosed. The driving voltage of the OLED can be lowered and the luminous efficiency and the luminous lifespan of the OLED can be maximized or increased by adding the organic compound into an emissive layer of the OLED.

Abstract: A cable management bracket includes a frame and a buckle member. The frame includes a first side portion and a second side portion, wherein the first side portion is opposite to the second side portion. The first side portion has a pivot hole, a first restraining portion and a second restraining portion, wherein the first restraining portion is located between the pivot hole and the second restraining portion. The second side portion has a first engaging portion. The buckle member includes a pivot portion and a second engaging portion. The pivot portion is inserted into the pivot hole and sandwiched in between the first restraining portion and the second restraining portion. The second engaging portion is rotatably engaged with the first engaging portion.

Abstract: The present invention relates to a novel compound (formula I), which has cancer treatment activity. The present invention also relates to a preparation method for the compound and a pharmaceutical composition containing the compound.

Abstract: A smart door lock assembly includes a lock cylinder, a lock cylinder mounting block, a driving motor, and a driving control board. A driving gear is arranged on a movable end of the driving motor. The lock cylinder passes through and is mounted in the lock cylinder mounting block. A driven gear coaxial with the lock cylinder is arranged on the lock cylinder mounting block. The driven gear is driven by the driving gear. The driving control board determines whether an external input unlocking command is right and controls the driving motor to unlock the smart door lock assembly when the external input unlocking command is right. The driving motor has a virtual position in a process of driving the driving gear.

Abstract: The present invention provides novel methods for treating and preventing colorectal cancer in a subject by administering a composition comprising ?-galactosidase, a bacterial culture capable of producing ?-galactosidase, such as an S. thermophilus culture, or a fraction of the culture comprising ?-galactosidase. A kit useful for such methods is also provided. In addition, the present invention provides a composition for treating or preventing colon cancer.

Abstract: A soft switching sub-circuit forming part of or for use with a circuit. The soft switching sub-circuit comprises a bridge switching circuit. The soft switching sub-circuit is configured and operable to provide a varying current output that tracks output current from the bridge switching circuit to create a substantially zero current through at least one switch component of the bridge switching circuit to enable soft switching.

Abstract: According to examples, an apparatus may include a processor and a memory on which are stored machine-readable instructions that when executed by the processor, may cause the processor to track traffic events and user interface (UI) events in parallel and record a first event of a hybrid test script. The first event may be recorded in a traffic mode to record one or more of the traffic events. The processor may transition from the traffic mode to a UI mode and, responsive to the transition from the traffic mode to the UI mode, may share session data between the traffic events and the UI events. Based on the session data, the processor may record a second event of the hybrid test script in the UI mode.

Abstract: A memory device includes a gate electrode, a gate insulating layer formed on the gate electrode, a tunneling insulating layer stacked on the gate insulating layer, a channel layer stacked on the tunneling insulating layer, and a source electrode and a drain electrode formed on the channel layer to be spaced apart from each other. The tunneling insulating layer suppresses tunneling of charges from any one of the channel layer and the gate electrode by a voltage applied to each of the gate electrode and the drain electrode, and a density of tunneled charges is set according to the voltage applied to the drain electrode to output and store multiple current levels.

Abstract: The present invention provides for compositions and methods for treating colorectal cancer or for reducing the risk of developing the disease in an individual.